Comparison results
Results: Differences Similar | ✘A26 | ✘D72.1 | ||||||||||
Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
Distinctive symptoms | ||||||||||||
Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
Register, to see more distinctive signs of diseases and studies | — | 18% | ||||||||||
cook | 100% | — | ||||||||||
increased ESR | — | 11% | ||||||||||
itching veins | 90% | — | ||||||||||
basophilia | — | 10% | ||||||||||
arthropathy | 85% | — | ||||||||||
neutropenia | — | 8% | ||||||||||
arthritis | 78% | — | ||||||||||
lymphocytosis | — | 8% | ||||||||||
burning in the veins | 77% | — | ||||||||||
hematocrit is reduced | — | 7% | ||||||||||
skin problems | 80% | 2% | ||||||||||
with reactive protein increased | — | 7% | ||||||||||
erysipeloid | 68% | — | ||||||||||
protein with increased | — | 6% | ||||||||||
skin itching redness | 64% | — | ||||||||||
piebaldism | — | 6% | ||||||||||
burning in the body | 64% | — | ||||||||||
neutrophilosis | — | 6% | ||||||||||
serous meningitis | 63% | — | ||||||||||
leukocyturia | — | 6% | ||||||||||
erysipelas | 61% | — | ||||||||||
leukocytosis | — | 6% | ||||||||||
suppuration of the skin | 64% | 2% | ||||||||||
with anemia | — | 4% | ||||||||||
bubbles on the skin | 59% | — | ||||||||||
albinism | — | 4% | ||||||||||
bronchopneumonia | 59% | — | ||||||||||
chediak-higashi syndrome | — | 4% | ||||||||||
itching of the body | 58% | — | ||||||||||
hemophagocytic syndrome | — | 3% | ||||||||||
lethargy with fever | 56% | — | ||||||||||
mental weakness | — | 3% | ||||||||||
burning itching | 56% | — | ||||||||||
tendency to bleed | — | 3% | ||||||||||
intoxication | 56% | — | ||||||||||
immunodeficiency | — | 3% | ||||||||||
joint soreness | 55% | — | ||||||||||
hemorrhagic fevers | — | 3% | ||||||||||
swelling of joints | 55% | — | ||||||||||
pancytopenia | — | 3% | ||||||||||
redness of the joints | 54% | — | ||||||||||
primary immunodeficiency | — | 3% | ||||||||||
burning of the skin | 53% | — | ||||||||||
lymphadenitis in children | — | 3% | ||||||||||
peeling | 53% | — | ||||||||||
consequences of infection | — | 2% | ||||||||||
high temperature | 56% | 2% | ||||||||||
epilepsy in children | — | 2% | ||||||||||
severe fever | 52% | — | ||||||||||
paresis | — | 2% | ||||||||||
infectious arthritis | 52% | — | ||||||||||
weakness after illness | — | 2% | ||||||||||
hemorrhages on the skin | 51% | — | ||||||||||
enlarged liver | — | 2% | ||||||||||
rash on the body | 50% | — | ||||||||||
skin anesthesia | — | 2% | ||||||||||
restriction of movement | 50% | — | ||||||||||
smart baby | — | 2% | ||||||||||
meningitis | 50% | — | ||||||||||
muscle weakness | — | 2% | ||||||||||
swelling of the skin | 50% | — | ||||||||||
convulsions | — | 2% | ||||||||||
endocarditis | 49% | — | ||||||||||
insensitivity to pain | — | 2% | ||||||||||
blue skin | 48% | — | ||||||||||
bleeding | — | 2% | ||||||||||
inflammation of the brain | 48% | — | ||||||||||
weakness | — | 2% | ||||||||||
joint deformation | 48% | — | ||||||||||
childhood diseases | — | 2% | ||||||||||
subfebrile condition | 47% | — | ||||||||||
epilepsy | — | 2% | ||||||||||
lymphadenitis | 49% | 2% | ||||||||||
bleeding | — | 2% | ||||||||||
burns | 45% | — | ||||||||||
purulent lymphadenitis | — | 2% | ||||||||||
itchy skin | 45% | — | ||||||||||
somatoform dysfunction of the autonomic nervous system | — | 2% | ||||||||||
smokes | 44% | — | ||||||||||
photophobia | — | 2% | ||||||||||
general intoxication syndrome | 44% | — | ||||||||||
convulsive syndrome in children | — | 2% | ||||||||||
pneumonia | 44% | — | ||||||||||
hepatosplenomegaly | — | 2% | ||||||||||
periods of exacerbation | 43% | — | ||||||||||
neuroses in children | — | 2% | ||||||||||
patient is motionless | 43% | — | ||||||||||
eosinophilia | — | 2% | ||||||||||
wounds | 41% | — | ||||||||||
neurological disorders | — | 2% | ||||||||||
cancer | 40% | — | ||||||||||
intellectual disabilities in children | — | 2% | ||||||||||
cardiac disorder | 39% | — | ||||||||||
enlargement of the liver and spleen | — | 2% | ||||||||||
swelling | 39% | — | ||||||||||
epilepsy attacks | — | 2% | ||||||||||
angiopathy | 39% | — | ||||||||||
cognitive disorders | — | 2% | ||||||||||
oncology | 37% | — | ||||||||||
enlargement of the spleen | — | 2% | ||||||||||
treatment with antibiotics | 41% | 2% | ||||||||||
mental retardation | — | 2% | ||||||||||
damage to the nervous system | 39% | 2% | ||||||||||
neurosis | — | 2% | ||||||||||
weakness at temperature | — | 2% | ||||||||||
fungus | — | 2% | ||||||||||
lymph node lesion | — | 2% |
Instructions
Video
|